Literature DB >> 10667841

Cell cycle regulation and inhibition of de novo pyrimidine biosynthesis by leflunomide.

H U Schorlemmer1, U Milbert, D Zeitter, G Haun, M Wunschel, R R Bartlett.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10667841     DOI： 10.1007/s000110050544

Source DB:  PubMed          Journal:  Inflamm Res        ISSN： 1023-3830            Impact factor:   4.575


× No keyword cloud information.
  2 in total

Review 1.  Update on immunopathogenesis and immunotherapy in multiple sclerosis.

Authors:  Rebecca C Selter; Bernhard Hemmer
Journal:  Immunotargets Ther       Date:  2013-04-25

2.  Therapeutic response to leflunomide in combo therapy and monotherapy is associated to serum teriflunomide (A77 1726) levels.

Authors:  Nicte S Fajardo-Robledo; Heriberto Jacobo-Cuevas; Edsaul E Perez-Guerrero; Esther G Corona-Sanchez; A Miriam Saldaña-Cruz; Elba M Romero-Tejeda; N Alejandra Rodriguez-Jimenez; Sylvia E Totsuka-Sutto; Rocio I Lopez-Roa; Juan M Ponce-Guarneros; M Fabiola Alcaraz-Lopez; Sergio Cerpa-Cruz; J Francisco Muñoz-Valle; E German Cardona-Muñoz; Laura Gonzalez-Lopez; Jorge I Gamez-Nava
Journal:  Sci Rep       Date:  2022-02-03       Impact factor: 4.379
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.